Bahaa Gamal Al-Din Mohammad Yousef

Faculty of Pharmacy

Assiut University

Department
Department of Pharmaceutical Organic Chemistry
Fax No
+20882080774
Email:
bgyoussif2@gmail.com
MIS Email
bahaa.youssif@pharm.aun.edu.eg
Mobile
01044353895
Office
0020882411883 - 0020882411883
Google Scholar
google_scholar

Ph.D. . in Pharmaceutical Sciences (Pharmaceutical Organic Chemistry) , Faculty of Pharmacy, Assiut University , 2012
M. Sc. In Pharmaceutical Sciences (Pharmaceutical Organic Chemistry) , Faculty of Pharmacy, Assiut University , 2005
B. Sc. In Pharmaceutical Sciences () , Faculty of Pharmacy, Assiut University , 2000


Associate Professor Faculty of Pharmacy, ِِAssiut University , 2017

Lecturer Faculty of Pharmacy, Assiut University , 2012

Assistant Lecturer Faculty of Pharmacy, Assiut University , 2005

Demonstrator Faculty of Pharmacy, Assiut University , 2000
No. Title سنة البحث
25 Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3-(2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFRWT/EGFRT790M inhibitors 2023
26 Synthesis, Antioxidant and Antiproliferative Actions of 4-(1,2,3-Triazol-1-yl) Quinolin-2(1H)-Ones as Multi-Target Inhibitors 2023
27 Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity 2023
28 Synthesis and antiproliferative Potential of thiazole and 4-thiazolidinone Containing Motifs as dual inhibitors of EGFR and BRAFV600E 2023
29 Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-Indole-2-Carboxylate and Pyrrolo[3,4-b]indol-3-one Derivatives as Potent Inhibitors of EGFRT790M/BRAFV600E Pathways 2023
30 Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action 2023
31 Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents 2023
32 Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities 2022

MemberShip